Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 14 entries
Sorted by: Best Match Show Resources per page
Effect of nicotine on the structure of cochlea of guinea pigs.

Anatomy & cell biology

Abdel-Hafez AM, Elgayar SA, Husain OA, Thabet HS.
PMID: 25276475
Anat Cell Biol. 2014 Sep;47(3):162-70. doi: 10.5115/acb.2014.47.3.162. Epub 2014 Sep 23.

Smoking has been positively associated with hearing loss in human. However, its effect on the cochlea has not been previously evaluated. Aim of work is to investigate the effect of nicotine, which is the primary pharmacological component of tobacco,...

Cite
Abdel-Hafez AM, Elgayar SA, Husain OA, et al. Effect of nicotine on the structure of cochlea of guinea pigs. Anat Cell Biol. 2014;47(3):162-70doi: 10.5115/acb.2014.47.3.162.
Abdel-Hafez, A. M., Elgayar, S. A., Husain, O. A., & Thabet, H. S. (2014). Effect of nicotine on the structure of cochlea of guinea pigs. Anatomy & cell biology, 47(3), 162-70. https://doi.org/10.5115/acb.2014.47.3.162
Abdel-Hafez, Amel M M, et al. "Effect of nicotine on the structure of cochlea of guinea pigs." Anatomy & cell biology vol. 47,3 (2014): 162-70. doi: https://doi.org/10.5115/acb.2014.47.3.162
Abdel-Hafez AM, Elgayar SA, Husain OA, Thabet HS. Effect of nicotine on the structure of cochlea of guinea pigs. Anat Cell Biol. 2014 Sep;47(3):162-70. doi: 10.5115/acb.2014.47.3.162. Epub 2014 Sep 23. PMID: 25276475; PMCID: PMC4178191.
Copy Download .nbib Format: NLM
Testing efficacy of the nicotine protection of the substantia nigra pars compacta in a rat Parkinson disease model. Ultrastructure study.

Ultrastructural pathology

Elgayar SAM, Hussein OA, Mubarak HA, Ismaiel AM, Gomaa AMS.
PMID: 35001795
Ultrastruct Pathol. 2022 Jan 10;1-17. doi: 10.1080/01913123.2021.2015499. Epub 2022 Jan 10.

Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) with subsequent motor manifestations. This study aimed to assess the ameliorative effects of nicotine, in rotenone-induced PD rat model. Thirty adult...

Cite
Elgayar SAM, Hussein OA, Mubarak HA, et al. Testing efficacy of the nicotine protection of the substantia nigra pars compacta in a rat Parkinson disease model. Ultrastructure study. Ultrastruct Pathol. 2022;1-17doi: 10.1080/01913123.2021.2015499.
Elgayar, S. A. M., Hussein, O. A., Mubarak, H. A., Ismaiel, A. M., & Gomaa, A. M. S. (2022). Testing efficacy of the nicotine protection of the substantia nigra pars compacta in a rat Parkinson disease model. Ultrastructure study. Ultrastructural pathology, 1-17. https://doi.org/10.1080/01913123.2021.2015499
Elgayar, S A M, et al. "Testing efficacy of the nicotine protection of the substantia nigra pars compacta in a rat Parkinson disease model. Ultrastructure study." Ultrastructural pathology vol. (2022): 1-17. doi: https://doi.org/10.1080/01913123.2021.2015499
Elgayar SAM, Hussein OA, Mubarak HA, Ismaiel AM, Gomaa AMS. Testing efficacy of the nicotine protection of the substantia nigra pars compacta in a rat Parkinson disease model. Ultrastructure study. Ultrastruct Pathol. 2022 Jan 10;1-17. doi: 10.1080/01913123.2021.2015499. Epub 2022 Jan 10. PMID: 35001795.
Copy Download .nbib Format: NLM
Nicotine impact on rat substantia nigra compacta.

Anatomy & cell biology

Elgayar SAM, Hussein OA, Mubarak HA, Ismaiel AM, Gomaa AMS.
PMID: 33782217
Anat Cell Biol. 2021 Mar 31;54(1):112-123. doi: 10.5115/acb.20.267.

Nicotine neuronal interactions exert an adverse potential in some brain regions and a significant link has been established between tobacco smoke/nicotine and vascular impairment. This work addresses nicotine impact on various components of the substantia nigra compacta (SNc) in...

Cite
Elgayar SAM, Hussein OA, Mubarak HA, et al. Nicotine impact on rat substantia nigra compacta. Anat Cell Biol. 2021;54(1):112-123doi: 10.5115/acb.20.267.
Elgayar, S. A. M., Hussein, O. A., Mubarak, H. A., Ismaiel, A. M., & Gomaa, A. M. S. (2021). Nicotine impact on rat substantia nigra compacta. Anatomy & cell biology, 54(1), 112-123. https://doi.org/10.5115/acb.20.267
Elgayar, Sanaa A M, et al. "Nicotine impact on rat substantia nigra compacta." Anatomy & cell biology vol. 54,1 (2021): 112-123. doi: https://doi.org/10.5115/acb.20.267
Elgayar SAM, Hussein OA, Mubarak HA, Ismaiel AM, Gomaa AMS. Nicotine impact on rat substantia nigra compacta. Anat Cell Biol. 2021 Mar 31;54(1):112-123. doi: 10.5115/acb.20.267. PMID: 33782217; PMCID: PMC8017450.
Copy Download .nbib Format: NLM
Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Helmy SA, El-Mofty S, El Gayar AM, El-Sherbiny IM, El-Far YM.
PMID: 34749055
Biomed Pharmacother. 2022 Jan;145:112376. doi: 10.1016/j.biopha.2021.112376. Epub 2021 Nov 05.

AIM: Doxorubicin/Cyclophosphamide (AC) is one of the standard adjuvant anthracycline-containing regimens that is still in use for breast cancer treatment. Cancer cell resistance and AC-induced side effects make treatment suboptimal and worsen patients' quality of life. This study aimed...

Cite
Helmy SA, El-Mofty S, El Gayar AM, et al. Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment. Biomed Pharmacother. 2021;145:112376doi: 10.1016/j.biopha.2021.112376.
Helmy, S. A., El-Mofty, S., El Gayar, A. M., El-Sherbiny, I. M., & El-Far, Y. M. (2022). Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 145112376. https://doi.org/10.1016/j.biopha.2021.112376
Helmy, Sahar A, et al. "Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 145 (2022): 112376. doi: https://doi.org/10.1016/j.biopha.2021.112376
Helmy SA, El-Mofty S, El Gayar AM, El-Sherbiny IM, El-Far YM. Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment. Biomed Pharmacother. 2022 Jan;145:112376. doi: 10.1016/j.biopha.2021.112376. Epub 2021 Nov 05. PMID: 34749055.
Copy Download .nbib Format: NLM
Nitric Oxide is a Potential Diagnostic Marker for Hepatocellular Carcinoma.

Scientia pharmaceutica

Eissa LA, Eisa NH, Ebrahim MA, Ragab M, El-Gayar AM.
PMID: 24106672
Sci Pharm. 2013 Aug 08;81(3):763-75. doi: 10.3797/scipharm.1307-09. Print 2013.

Hepatocellular carcinoma (HCC) is the fifth most common cancer in men and the seventh most common in women. This cancer varies widely in incidence throughout the world, with rising incidence in Egypt. HCC is considered the second most frequent...

Cite
Eissa LA, Eisa NH, Ebrahim MA, et al. Nitric Oxide is a Potential Diagnostic Marker for Hepatocellular Carcinoma. Sci Pharm. 2013;81(3):763-75doi: 10.3797/scipharm.1307-09.
Eissa, L. A., Eisa, N. H., Ebrahim, M. A., Ragab, M., & El-Gayar, A. M. (2013). Nitric Oxide is a Potential Diagnostic Marker for Hepatocellular Carcinoma. Scientia pharmaceutica, 81(3), 763-75. https://doi.org/10.3797/scipharm.1307-09
Eissa, Laila A, et al. "Nitric Oxide is a Potential Diagnostic Marker for Hepatocellular Carcinoma." Scientia pharmaceutica vol. 81,3 (2013): 763-75. doi: https://doi.org/10.3797/scipharm.1307-09
Eissa LA, Eisa NH, Ebrahim MA, Ragab M, El-Gayar AM. Nitric Oxide is a Potential Diagnostic Marker for Hepatocellular Carcinoma. Sci Pharm. 2013 Aug 08;81(3):763-75. doi: 10.3797/scipharm.1307-09. Print 2013. PMID: 24106672; PMCID: PMC3791938.
Copy Download .nbib Format: NLM
Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Helmy SA, El-Mofty S, El Gayar AM, El-Sherbiny IM, El-Far YM.
PMID: 34749055
Biomed Pharmacother. 2021 Nov 05;145:112376. doi: 10.1016/j.biopha.2021.112376. Epub 2021 Nov 05.

AIM: Doxorubicin/Cyclophosphamide (AC) is one of the standard adjuvant anthracycline-containing regimens that is still in use for breast cancer treatment. Cancer cell resistance and AC-induced side effects make treatment suboptimal and worsen patients' quality of life. This study aimed...

Cite
Helmy SA, El-Mofty S, El Gayar AM, et al. Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment. Biomed Pharmacother. 2021;145:112376doi: 10.1016/j.biopha.2021.112376.
Helmy, S. A., El-Mofty, S., El Gayar, A. M., El-Sherbiny, I. M., & El-Far, Y. M. (2021). Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 145112376. https://doi.org/10.1016/j.biopha.2021.112376
Helmy, Sahar A, et al. "Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 145 (2021): 112376. doi: https://doi.org/10.1016/j.biopha.2021.112376
Helmy SA, El-Mofty S, El Gayar AM, El-Sherbiny IM, El-Far YM. Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment. Biomed Pharmacother. 2021 Nov 05;145:112376. doi: 10.1016/j.biopha.2021.112376. Epub 2021 Nov 05. PMID: 34749055.
Copy Download .nbib Format: NLM
The Potential of Optimized Liposomes in Enhancement of Cytotoxicity and Apoptosis of Encapsulated Egyptian Propolis on Hep-2 Cell Line.

Pharmaceutics

El-Aziz EAEA, Elgayar SF, Mady FM, Abourehab MAS, Hasan OA, Reda LM, Alaaeldin E.
PMID: 34959465
Pharmaceutics. 2021 Dec 17;13(12). doi: 10.3390/pharmaceutics13122184.

PURPOSE: Development of pharmaceutical dosage forms of natural products has gained great interest recently. Propolis is a natural product with various active compounds and multiple pharmacological activities. Its resinous nature and low bioavailability were obstacles in the optimum use...

Cite
El-Aziz EAEA, Elgayar SF, Mady FM, et al. The Potential of Optimized Liposomes in Enhancement of Cytotoxicity and Apoptosis of Encapsulated Egyptian Propolis on Hep-2 Cell Line. Pharmaceutics. 2021;13(12)doi: 10.3390/pharmaceutics13122184.
El-Aziz, E. A. E. A., Elgayar, S. F., Mady, F. M., Abourehab, M. A. S., Hasan, O. A., Reda, L. M., & Alaaeldin, E. (2021). The Potential of Optimized Liposomes in Enhancement of Cytotoxicity and Apoptosis of Encapsulated Egyptian Propolis on Hep-2 Cell Line. Pharmaceutics, 13(12), . https://doi.org/10.3390/pharmaceutics13122184
El-Aziz, Enas Alaa El-Din Abd, et al. "The Potential of Optimized Liposomes in Enhancement of Cytotoxicity and Apoptosis of Encapsulated Egyptian Propolis on Hep-2 Cell Line." Pharmaceutics vol. 13,12 (2021). doi: https://doi.org/10.3390/pharmaceutics13122184
El-Aziz EAEA, Elgayar SF, Mady FM, Abourehab MAS, Hasan OA, Reda LM, Alaaeldin E. The Potential of Optimized Liposomes in Enhancement of Cytotoxicity and Apoptosis of Encapsulated Egyptian Propolis on Hep-2 Cell Line. Pharmaceutics. 2021 Dec 17;13(12). doi: 10.3390/pharmaceutics13122184. PMID: 34959465.
Copy Download .nbib Format: NLM
Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma.

Scientia pharmaceutica

Hammouda NE, Salah El-Din MA, El-Shishtawy MM, El-Gayar AM.
PMID: 28282874
Sci Pharm. 2017 Mar 08;85(1). doi: 10.3390/scipharm85010009.

Elevated serum levels of cystatin C are found to be related to poor outcome and metastatic potential of some malignant disorders. To evaluate the clinical prominence of serum cystatin C in diffuse large B-cell lymphoma (DLBCL), blood samples were...

Cite
Hammouda NE, Salah El-Din MA, El-Shishtawy MM, et al. Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma. Sci Pharm. 2017;85(1)doi: 10.3390/scipharm85010009.
Hammouda, N. E., Salah El-Din, M. A., El-Shishtawy, M. M., & El-Gayar, A. M. (2017). Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma. Scientia pharmaceutica, 85(1), . https://doi.org/10.3390/scipharm85010009
Hammouda, Nada E, et al. "Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma." Scientia pharmaceutica vol. 85,1 (2017). doi: https://doi.org/10.3390/scipharm85010009
Hammouda NE, Salah El-Din MA, El-Shishtawy MM, El-Gayar AM. Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma. Sci Pharm. 2017 Mar 08;85(1). doi: 10.3390/scipharm85010009. PMID: 28282874; PMCID: PMC5388146.
Copy Download .nbib Format: NLM
Morphology of cat vomeronasal organ non-sensory epithelium during postnatal development.

Anatomy & cell biology

Elgayar SAM, Saad-Eldin HM, Haussein OA.
PMID: 28417051
Anat Cell Biol. 2017 Mar;50(1):17-25. doi: 10.5115/acb.2017.50.1.17. Epub 2017 Mar 29.

The vomeronasal organ has an important role in mammal's social and sexual behaviours. In addition, it mediates defensive behavior through detection of protein pheromone homologues. In this work, a detailed morphological description of the postnatal development of the non-sensory...

Cite
Elgayar SAM, Saad-Eldin HM, Haussein OA. Morphology of cat vomeronasal organ non-sensory epithelium during postnatal development. Anat Cell Biol. 2017;50(1):17-25doi: 10.5115/acb.2017.50.1.17.
Elgayar, S. A. M., Saad-Eldin, H. M., & Haussein, O. A. (2017). Morphology of cat vomeronasal organ non-sensory epithelium during postnatal development. Anatomy & cell biology, 50(1), 17-25. https://doi.org/10.5115/acb.2017.50.1.17
Elgayar, Sanaa A M, et al. "Morphology of cat vomeronasal organ non-sensory epithelium during postnatal development." Anatomy & cell biology vol. 50,1 (2017): 17-25. doi: https://doi.org/10.5115/acb.2017.50.1.17
Elgayar SAM, Saad-Eldin HM, Haussein OA. Morphology of cat vomeronasal organ non-sensory epithelium during postnatal development. Anat Cell Biol. 2017 Mar;50(1):17-25. doi: 10.5115/acb.2017.50.1.17. Epub 2017 Mar 29. PMID: 28417051; PMCID: PMC5386922.
Copy Download .nbib Format: NLM
Evaluation of Serum Levels of HER2, MMP-9, Nitric Oxide, and Total Antioxidant Capacity in Egyptian Breast Cancer Patients: Correlation with Clinico-Pathological Parameters.

Scientia pharmaceutica

Rashad YA, Elkhodary TR, El-Gayar AM, Eissa LA.
PMID: 24634847
Sci Pharm. 2013 Sep 22;82(1):129-45. doi: 10.3797/scipharm.1306-18. Print 2014.

Breast cancer is by far the most common cancer in women worldwide and the main cause of cancer-related mortality. Breast cancer accounts for 38% of all malignancies among Egyptian women. The aim of our study was to evaluate the...

Cite
Rashad YA, Elkhodary TR, El-Gayar AM, et al. Evaluation of Serum Levels of HER2, MMP-9, Nitric Oxide, and Total Antioxidant Capacity in Egyptian Breast Cancer Patients: Correlation with Clinico-Pathological Parameters. Sci Pharm. 2013;82(1):129-45doi: 10.3797/scipharm.1306-18.
Rashad, Y. A., Elkhodary, T. R., El-Gayar, A. M., & Eissa, L. A. (2014). Evaluation of Serum Levels of HER2, MMP-9, Nitric Oxide, and Total Antioxidant Capacity in Egyptian Breast Cancer Patients: Correlation with Clinico-Pathological Parameters. Scientia pharmaceutica, 82(1), 129-45. https://doi.org/10.3797/scipharm.1306-18
Rashad, Yara A, et al. "Evaluation of Serum Levels of HER2, MMP-9, Nitric Oxide, and Total Antioxidant Capacity in Egyptian Breast Cancer Patients: Correlation with Clinico-Pathological Parameters." Scientia pharmaceutica vol. 82,1 (2014): 129-45. doi: https://doi.org/10.3797/scipharm.1306-18
Rashad YA, Elkhodary TR, El-Gayar AM, Eissa LA. Evaluation of Serum Levels of HER2, MMP-9, Nitric Oxide, and Total Antioxidant Capacity in Egyptian Breast Cancer Patients: Correlation with Clinico-Pathological Parameters. Sci Pharm. 2013 Sep 22;82(1):129-45. doi: 10.3797/scipharm.1306-18. Print 2014. PMID: 24634847; PMCID: PMC3951224.
Copy Download .nbib Format: NLM
Development of an Arabic version of the National Eye Institute Visual Function Questionnaire as a tool to study eye diseases patients in Egypt.

International journal of ophthalmology

Abdelfattah NS, Amgad M, Salama AA, Israel ME, Elhawary GA, Radwan AE, Elgayar MM, El Nakhal TM, Elkhateb IT, Hashem HA, Embaby DK, Elabd AA, Elwy RK, Yacoub MS, Salem H, Abdel-Baqy M, Kassem A.
PMID: 25349812
Int J Ophthalmol. 2014 Oct 18;7(5):891-7. doi: 10.3980/j.issn.2222-3959.2014.05.27. eCollection 2014.

AIM: To develop and test an Arabic version of the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25).METHODS: NEI-VFQ-25 was translated into Arabic according to WHO translation guidelines. We enrolled adult consenting patients with bilateral chronic eye diseases who presented...

Cite
Abdelfattah NS, Amgad M, Salama AA, et al. Development of an Arabic version of the National Eye Institute Visual Function Questionnaire as a tool to study eye diseases patients in Egypt. Int J Ophthalmol. 2014;7(5):891-7doi: 10.3980/j.issn.2222-3959.2014.05.27.
Abdelfattah, N. S., Amgad, M., Salama, A. A., Israel, M. E., Elhawary, G. A., Radwan, A. E., Elgayar, M. M., El Nakhal, T. M., Elkhateb, I. T., Hashem, H. A., Embaby, D. K., Elabd, A. A., Elwy, R. K., Yacoub, M. S., Salem, H., Abdel-Baqy, M., & Kassem, A. (2014). Development of an Arabic version of the National Eye Institute Visual Function Questionnaire as a tool to study eye diseases patients in Egypt. International journal of ophthalmology, 7(5), 891-7. https://doi.org/10.3980/j.issn.2222-3959.2014.05.27
Abdelfattah, Nizar Saleh, et al. "Development of an Arabic version of the National Eye Institute Visual Function Questionnaire as a tool to study eye diseases patients in Egypt." International journal of ophthalmology vol. 7,5 (2014): 891-7. doi: https://doi.org/10.3980/j.issn.2222-3959.2014.05.27
Abdelfattah NS, Amgad M, Salama AA, Israel ME, Elhawary GA, Radwan AE, Elgayar MM, El Nakhal TM, Elkhateb IT, Hashem HA, Embaby DK, Elabd AA, Elwy RK, Yacoub MS, Salem H, Abdel-Baqy M, Kassem A. Development of an Arabic version of the National Eye Institute Visual Function Questionnaire as a tool to study eye diseases patients in Egypt. Int J Ophthalmol. 2014 Oct 18;7(5):891-7. doi: 10.3980/j.issn.2222-3959.2014.05.27. eCollection 2014. PMID: 25349812; PMCID: PMC4206900.
Copy Download .nbib Format: NLM
Sesamol Upregulates Death Receptors and Acts as a Chemosensitizer in Solid Ehrlich Carcinoma Model in Mice.

Nutrition and cancer

Abd Elrazik NA, El-Mesery M, El-Karef A, Eissa LA, El Gayar AM.
PMID: 33439054
Nutr Cancer. 2021 Jan 13;1-15. doi: 10.1080/01635581.2020.1871496. Epub 2021 Jan 13.

AIMS: The aim of the present study was to investigate the anti-tumor effect of sesamol (SML), a nutritional phenolic compound of sesame, in solid Ehrlich carcinoma (SEC) model in mice and its ability to enhance doxorubicin (DOX) anti-tumor activity....

Cite
Abd Elrazik NA, El-Mesery M, El-Karef A, et al. Sesamol Upregulates Death Receptors and Acts as a Chemosensitizer in Solid Ehrlich Carcinoma Model in Mice. Nutr Cancer. 2021;1-15doi: 10.1080/01635581.2020.1871496.
Abd Elrazik, N. A., El-Mesery, M., El-Karef, A., Eissa, L. A., & El Gayar, A. M. (2021). Sesamol Upregulates Death Receptors and Acts as a Chemosensitizer in Solid Ehrlich Carcinoma Model in Mice. Nutrition and cancer, 1-15. https://doi.org/10.1080/01635581.2020.1871496
Abd Elrazik, Nesma A, et al. "Sesamol Upregulates Death Receptors and Acts as a Chemosensitizer in Solid Ehrlich Carcinoma Model in Mice." Nutrition and cancer vol. (2021): 1-15. doi: https://doi.org/10.1080/01635581.2020.1871496
Abd Elrazik NA, El-Mesery M, El-Karef A, Eissa LA, El Gayar AM. Sesamol Upregulates Death Receptors and Acts as a Chemosensitizer in Solid Ehrlich Carcinoma Model in Mice. Nutr Cancer. 2021 Jan 13;1-15. doi: 10.1080/01635581.2020.1871496. Epub 2021 Jan 13. PMID: 33439054.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 14 entries